Related Experiment Video

Updated: Jun 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1

Karen Walker1, Meenal Padhiar

  • 1Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK. karen.walker@thomsonreuters.com

Idrugs : the Investigational Drugs Journal
|December 22, 2009
PubMed

Insights

This report summarizes novel cancer therapeutics and molecular targets from a major oncology conference. It highlights investigational drugs like XL-139 and Reolysin, advancing cancer treatment research.

Area of Science:

  • Oncology
  • Drug Development
  • Molecular Biology

Background:

  • The 21st international symposium of the American Association for Cancer Research (AACR), National Cancer Institute (NCI), and European Organisation for Research and Treatment of Cancer (EORTC) convened to discuss cancer research.
  • Key areas of focus included the advancement of therapeutics and identification of molecular targets for cancer treatment.

Purpose of the Study:

  • To report on selected presentations from the symposium focusing on the development of novel anti-cancer drugs.
  • To provide an overview of investigational therapeutics discussed at the conference.

Main Methods:

  • The report is based on presentations delivered at the 21st AACR, NCI, and EORTC international symposium.
  • Information on investigational drugs was compiled from conference proceedings and discussions.

Main Results:

  • Several novel investigational drugs were presented, including XL-139, SPC-3042, CH-5137291, SN-29966/SN-29926/SN-3000, withaferin-A, Reolysin, EZN-3889/EZN-3892, and CBP-501.
  • These agents represent diverse therapeutic strategies and molecular targets in oncology drug development.

Conclusions:

  • The symposium showcased significant progress in the development of new cancer therapeutics.
  • Ongoing research into novel molecular targets and drug candidates holds promise for future cancer treatment strategies.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...